Short Interest in Aclarion, Inc. (NASDAQ:ACON) Rises By 47.2%

Aclarion, Inc. (NASDAQ:ACON) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,810,000 shares, an increase of 47.2% from the December 15th total of 1,230,000 shares. Based on an average daily trading volume, of 6,370,000 shares, the days-to-cover ratio is presently 0.3 days. Approximately 17.4% of the shares of the company are sold short.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a research report on Friday, December 13th. Ascendiant Capital Markets dropped their price target on Aclarion from $1.50 to $1.30 and set a “buy” rating on the stock in a research note on Wednesday, November 27th.

Aclarion Stock Up 5.9 %

Shares of ACON stock opened at $0.05 on Friday. Aclarion has a 52 week low of $0.03 and a 52 week high of $3.85. The company has a 50-day simple moving average of $0.15 and a 200 day simple moving average of $0.20.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.